Bernard W. Downs

1.9k citations
45 papers · 1.1k · h-index 21

Impact in

Papers in

Co-authors
Eric R. Braverman (28 shared papers)Thomas J.H. Chen (23 shared papers)Kenneth Blum (32 shared papers)Roger L. Waite (16 shared papers)Mallory Kerner (14 shared papers)Seth H. Blum (15 shared papers)John Giordano (12 shared papers)Kenneth Blum (4 shared papers)
Journals
Advances in Therapy (4 papers)Molecular Neurobiology (3 papers)Food Production Processing and Nutrition (2 papers)Journal of the American College of Nutrition (1 paper)Current Neuropharmacology (1 paper)
Partner nations
United StatesTaiwanIndia

In The Last Decade

Bernard W. Downs

43 papers receiving 998 citations

Peers

Bernard W. Downs
Comparison fields: 5 of 103
  • Cellular and Molecular Neuroscience 402
  • Psychiatry and Mental health 269
  • Biological Psychiatry 30
  • Pharmacology 202
  • Behavioral Neuroscience 43
Replace Panayotis K. Thanos with:
Panayotis K. Thanos United States
Stefan Bleich Germany
Mohab Alexander United States
Hannu Naukkarinen Finland
Yasmene B. Shah United Kingdom
Barry V. O’Neill United Kingdom
Monique L. Smith United States
G J Wang United States
Joseph P. Schacht United States
Tiina Pohjalainen Finland
Bernard W. Downs relative to Panayotis K. Thanos United States Panayotis K. Thanos's profile →
Citations per field
00.5×1.5×2.0×
Panayotis K. Thanos · 1×
Citations per year

Countries citing papers authored by Bernard W. Downs

Since Specialization
Citations

This map shows the geographic impact of Bernard W. Downs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard W. Downs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard W. Downs more than expected).

Fields of papers citing papers by Bernard W. Downs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard W. Downs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard W. Downs. The network helps show where Bernard W. Downs may publish in the future.

Co-authors

The 25 scholars most cited alongside Bernard W. Downs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernard W. Downs Line = papers co-authored together Bernard W. Downs links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary
Theoretical Biology and Medical Modelling ·Kenneth Blum, Amanda LihChuan Chen, Thomas J.H. Chen, Eric R. Braverman, Jeffrey Reinking, Seth H. Blum, Kimberly Cassel, Bernard W. Downs, Roger L. Waite, Lonna Williams, Thomas J. Prihoda, Mallory Kerner, Tomás Palomo, David E. Comings, Howard Tung, Patrick Rhoades, Marlene Oscar‐Berman
2008114
2
Are dopaminergic genes involved in a predisposition to pathological aggression?
Medical Hypotheses ·Thomas J.H. Chen, Kenneth Blum, Daniel Mathews, Larry Fisher, Nancy Schnautz, Eric R. Braverman, John Schoolfield, Bernard W. Downs, David E. Comings
200587
3
Overcoming qEEG Abnormalities and Reward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D2Agonist Therapy: Part 2
Postgraduate Medicine ·Kenneth Blum, Thomas J.H. Chen, Siobhan Morse, John Giordano, Amanda Lih Chaun Chen, James T. Thompson, Cameron Allen, Andrew Smolen, Joel F. Lubar, Eric Stice, Bernard W. Downs, Roger L. Waite, Margaret Madigan, Mallory Kerner, Frank Fornari, Eric R. Braverman
201072
4
Neurogenetics of Dopaminergic Receptor Supersensitivity in Activation of Brain Reward Circuitry and Relapse: Proposing “Deprivation-Amplification Relapse Therapy” (DART)
Postgraduate Medicine ·Kenneth Blum, Thomas J.H. Chen, Bernard W. Downs, Abdalla Bowirrat, Roger L. Waite, Eric R. Braverman, Margaret Madigan, Marlene Oscar‐Berman, Nicholas A. DiNubile, Eric Stice, John Giordano, Siobhan Morse, Mark S. Gold
200961
5
Acute Intravenous Synaptamine Complex Variant KB220™ “Normalizes” Neurological Dysregulation in Patients during Protracted Abstinence from Alcohol and Opiates as Observed Using Quantitative Electroencephalographic and Genetic Analysis for Reward Polymorphisms: Part 1, Pilot Study with 2 Case Reports
Postgraduate Medicine ·David K. Miller, Abdalla Bowirrat, Matthew Manka, Merlene Miller, Stanley Stokes, Debra Manka, Cameron Allen, Charles E. Gant, Bernard W. Downs, Andrew Smolen, Emily Stevens, Swetha Yeldandi, Kenneth Blum
201046
6
Bioefficacy of a novel calcium–potassium salt of (−)-hydroxycitric acid
Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Bernard W. Downs, Manashi Bagchi, Gottumukkala V. Subbaraju, (unknown), Harry G. Preuss, Debasis Bagchi
200546
7
Reward deficiency syndrome in obesity: A preliminary cross-sectional trial with a genotrim variant
Advances in Therapy ·Kenneth Blum, Thomas J.H. Chen, Brian Meshkin, Bernard W. Downs, Cory A. Gordon, Seth H. Blum, Julie F. Mengucci, Eric R. Braverman, Vanessa Arcuri, Michael Varshavskiy, Roger Deutsch, Manuel Martinez-Pons
200645
8
Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability
Current Neuropharmacology ·Abdalla Bowirrat, Thomas J.H. Chen, Kenneth Blum, Margaret Madigan, John Bailey, Amanda Lih Chuan Chen, Bernard W. Downs, Eric R. Braverman, Radi Shahien, Roger L. Waite, Mallory Kerner, John Giordano, Siohban Morse, Marlene Oscar‐Berman, Mark S. Gold
201044
9
Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS)
Medical Hypotheses ·Kenneth Blum, Thomas J.H. Chen, Amanda L.H. Chen, Margaret Madigan, Bernard W. Downs, Roger L. Waite, Eric R. Braverman, Mallory Kerner, Abdalla Bowirrat, John Giordano, Harry Henshaw, Mark S. Gold
200943
10
Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: A hypothesis
Medical Hypotheses ·Kenneth Blum, Thomas J.H. Chen, Brian Meshkin, Roger L. Waite, Bernard W. Downs, Seth H. Blum, Julie F. Mengucci, Vanessa Arcuri, Eric R. Braverman, Tomás Palomo
200742
11
LG839: Anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome
Advances in Therapy ·Kenneth Blum, Amanda LC Chen, Thomas J.H. Chen, Patrick Rhoades, Thomas J. Prihoda, Bernard W. Downs, Roger L. Waite, Lonna Williams, Eric R. Braverman, Dasha Braverman, Vanessa Arcuri, Mallory Kerner, Seth H. Blum, Tomás Palomo
200841
12
Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions
Medical Hypotheses ·Amanda LC Chen, Thomas J.H. Chen, Roger L. Waite, Jeffrey Reinking, Howard Tung, Patrick Rhoades, Bernard W. Downs, Eric R. Braverman, Dasha Braverman, Mallory Kerner, Seth H. Blum, Nicholas A. DiNubile, David E. Smith, Marlene Oscar‐Berman, Thomas J. Prihoda, John Floyd, David O’Brien, H.H. Liu, Kenneth Blum
200834
13
Dopamine D2 receptor Taq A1 allele predicts treatment compliance of LG839 in a subset analysis of pilot study in the Netherlands
Kenneth Blum, Thomas J.H. Chen, Amanda LC Chen, Patrick Rhoades, Thomas J. Prihoda, Bernard W. Downs, Debasis Bagchi, Manashi Bagchi, Seth H. Blum, Lonna Williams, Eric R. Braverman, Mallory Kerner, Roger L. Waite, Brien Quirk, Lisa D. White, Jeffrey Reinking
200832
14
Correlation of the Taq1 dopamine D2 receptor gene and percent body fat in obese and screened control subjects: A preliminary report
Food & Function ·Amanda LC Chen, Kenneth Blum, Thomas J.H. Chen, John Giordano, Bernard W. Downs, David Han, Debmalya Barh, Eric R. Braverman
201131
15
Genotrim™, a DNA-customized nutrigenomic product, targets genetic factors of obesity: Hypothesizing a dopamine–glucose correlation demonstrating reward deficiency syndrome (RDS)
Medical Hypotheses ·Kenneth Blum, Thomas J.H. Chen, Brian Meshkin, Bernard W. Downs, Cory A. Gordon, Seth H. Blum, Julie F. Mangucci, Eric R. Braverman, Vanessa Arcuri, Roger Deutsch, Manuel Martínez Pons
200630
16
Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?
Molecular Neurobiology ·Kenneth Blum, Thomas J.H. Chen, John Bailey, Abdalla Bowirrat, John Femino, Amanda LC Chen, Thomas Simpatico, Siobhan Morse, John Giordano, Uma J Damle, Mallory Kerner, Eric R. Braverman, Frank Fornari, Bernard W. Downs, Cynthia Rector, Debmalya Barh, Marlene Oscar‐Berman
201126
17
High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial
Molecular Neurobiology ·Mark Moran, Kenneth Blum, Jessica V. Ponce, Lisa Lott, Marjorie C. Gondré‐Lewis, Sampada Badgaiyan, Raymond Brewer, Bernard W. Downs, Philip Fynman, Alexander Weingarten, Jean Lud Cadet, David E. Smith, David Baron, Panayotis K. Thanos, Edward J. Modestino, Rajendra D. Badgaiyan, Igor Elman, Mark S. Gold
202124
18
Synaptamine (SG8839),TM An Amino-Acid Enkephalinase Inhibition Nutraceutical Improves Recovery of Alcoholics, A Subtype of Reward Deficiency Syndrome (RDS)
Trends in Applied Sciences Research ·Kenneth Blum, Thomas J.H. Chen, Bernard W. Downs, Brian Meshkin, Seth H. Blum, Manuel Martínez Pons, Julie F. Mengucci, Roger L. Waite, Vanessa Arcuri, Michael Varshofsiky ., Eric R. Braverman
200723
19
Neuropsychopharmacology and Neurogenetic Aspects of Executive Functioning: Should Reward Gene Polymorphisms Constitute a Diagnostic Tool to Identify Individuals at Risk for Impaired Judgment?
Molecular Neurobiology ·Abdalla Bowirrat, Thomas J.H. Chen, Marlene Oscar‐Berman, Margaret Madigan, Amanda LH Chen, John Bailey, Eric R. Braverman, Mallory Kerner, John Giordano, Siobhan Morse, Bernard W. Downs, Roger L. Waite, Frank Fornari, Zaher Armaly, Kenneth Blum
201222
20
Nutrigenomic targeting of carbohydrate craving behavior: Can we manage obesity and aberrant craving behaviors with neurochemical pathway manipulation by Immunological Compatible Substances (nutrients) using a Genetic Positioning System (GPS) Map?
Medical Hypotheses ·Bernard W. Downs, Amanda LC Chen, Thomas J.H. Chen, Roger L. Waite, Eric R. Braverman, Mallory Kerner, Dasha Braverman, Patrick Rhoades, Thomas J. Prihoda, Tomás Palomo, Marlene Oscar‐Berman, Jeffrey Reinking, Seth H. Blum, Nicholas A. DiNubile, H.H. Liu, Kenneth Blum
200921

About Bernard W. Downs

Bernard W. Downs is a scholar working on Cellular and Molecular Neuroscience, Physiology, Psychiatry and Mental health, Molecular Biology and Pharmacology, having authored 45 papers that have together received 1.1k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (12 papers), Diet and metabolism studies (6 papers), Pharmacology and Obesity Treatment (5 papers), Pain Mechanisms and Treatments (4 papers), Attention Deficit Hyperactivity Disorder (4 papers), Adipose Tissue and Metabolism (3 papers), Nutrition, Genetics, and Disease (3 papers) and Obsessive-Compulsive Spectrum Disorders (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (402 citations), Psychiatry and Mental health (269 citations), Biological Psychiatry (30 citations), Pharmacology (202 citations) and Behavioral Neuroscience (43 citations). Bernard W. Downs has collaborated with scholars based in United States, Taiwan and India. Frequent co-authors include Eric R. Braverman, Thomas J.H. Chen, Kenneth Blum, Roger L. Waite, Mallory Kerner, Seth H. Blum, John Giordano, Kenneth Blum, Marlene Oscar‐Berman and Brian Meshkin. Their work appears in journals such as Advances in Therapy, Molecular Neurobiology, Food Production Processing and Nutrition, Journal of the American College of Nutrition and Current Neuropharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Panayotis K. ThanosBreakdown of academic impact, for papers by Stefan BleichBreakdown of academic impact, for papers by Mohab AlexanderBreakdown of academic impact, for papers by Hannu NaukkarinenBreakdown of academic impact, for papers by Yasmene B. ShahBreakdown of academic impact, for papers by Barry V. O’NeillBreakdown of academic impact, for papers by Monique L. SmithBreakdown of academic impact, for papers by G J WangBreakdown of academic impact, for papers by Joseph P. SchachtBreakdown of academic impact, for papers by Tiina Pohjalainen